The federal government will pay $2 million to settle a human rights class action brought by Indigenous Australians from the Ngaanyatjarraku community in Western Australia over allegedly discriminatory requirements for access to social security benefits.
Unilodge Australia faces a potential class action alleging the student housing agency shortchanged staff by paying them under the wrong award.
Construction company Delcon Civil is facing a lawsuit by a subcontractor seeking over $3.4 million in damages for alleged breach of contract relating to work on the North East Link project.
A “full-blooded carriage fight” is set down for next year between two competing class actions alleging dairy giant a2 Milk misled shareholders with an overly optimistic prediction of its infant formula sales.
Accounting giant Deloitte has lost its bid to throw out a former client’s lawsuit alleging negligence and fraud over a failed interposition under tax law that occurred more than 16 years ago.
A senior ACCC officer has been grilled on whether staff training on criminal cartel investigations was “inadequate” while the competition regulator ran a cartel probe into ANZ’s $2.5 billion share placement in 2016.
A Western Australian lawyer will face penalties and disciplinary action in the State Administrative Tribunal after nine professional misconduct findings were made against him, including a finding that he knowingly sought to mislead the Supreme Court.
The Full Federal Court has shot down plumbing company Repipe’s appeal of a decision rejecting its innovation patents for a claimed computer-implemented invention, saying it only addressed issues in business operations rather than improving on computer technology.
Qantas is locked in a legal battle with a US-based pilot training provider over failed negotiations concerning the development of a $35 million pilot academy in regional Queensland.
Swiss pharmaceutical company Biogen is considering a third patent infringement lawsuit against a drug maker to shield its monopoly in Australia for blockbuster multiple sclerosis drug Tecfidera from generic competition.